Zosano Pharma (ZSAN) Reaches $4.37 After 6.00% Down Move; Malvern Federal Bancorp Has 0.8 Sentiment

June 13, 2018 - By Marguerite Chambers

Malvern Federal Bancorp Inc (MLVF) investors sentiment decreased to 0.8 in 2018 Q1. It’s down -0.49, from 1.29 in 2017Q4. The ratio is negative, as 16 hedge funds started new and increased holdings, while 20 reduced and sold equity positions in Malvern Federal Bancorp Inc. The hedge funds in our database now possess: 3.94 million shares, down from 4.00 million shares in 2017Q4. Also, the number of hedge funds holding Malvern Federal Bancorp Inc in top ten holdings was flat from 2 to 2 for the same number . Sold All: 6 Reduced: 14 Increased: 15 New Position: 1.

The stock of Zosano Pharma Corporation (NASDAQ:ZSAN) is a huge mover today! The stock decreased 3.10% or $0.14 during the last trading session, reaching $4.37. About 83,671 shares traded. Zosano Pharma Corporation (NASDAQ:ZSAN) has declined 85.30% since June 13, 2017 and is downtrending. It has underperformed by 97.87% the S&P500. Some Historical ZSAN News: ; 22/05/2018 – ZOSANO APPOINTS STEVEN A. ELMS TO BOARD OF DIRECTORS; 16/03/2018 – Zosano Pharma: 103 Patients Have Enrolled in Study for Acute Treatment of Migraine; 22/05/2018 – Zosano Appoints Steven a. Elms to Bd of Directors; 16/03/2018 – ZOSANO PHARMA CORP – 100TH PATIENT HAS ENROLLED AND RECEIVED M207 IN LONG-TERM SAFETY STUDY FOR ACUTE TREATMENT OF MIGRAINE; 15/05/2018 – Telemetry Investments Buys New 1.2% Position in Zosano Pharma; 14/05/2018 – Stonepine Capital Buys New 1.7% Position in Zosano Pharma; 06/04/2018 – ADAGE CAPITAL PARTNERS GP, L.L.C. REPORTS 8.35 PCT PASSIVE STAKE IN ZOSANO PHARMA CORP AS OF MARCH 29 – SEC FILING; 06/04/2018 – ZOSANO PHARMA HOLDER ADAGE CAPITAL REPORTS PASSIVE STAKE; 03/04/2018 – Zosano Announces Closing of Public Offering of Common Stk; 06/04/2018 – ZOSANO PHARMA HOLDER ADAGE REPORTS NEW 8.4% PASSIVE STAKEThe move comes after 5 months negative chart setup for the $52.32M company. It was reported on Jun, 13 by Barchart.com. We have $4.11 PT which if reached, will make NASDAQ:ZSAN worth $3.14M less.

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. The company has market cap of $52.32 million. The Company’s lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. It currently has negative earnings.

Among 3 analysts covering Zosano Pharma (NASDAQ:ZSAN), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Zosano Pharma had 5 analyst reports since September 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Roth Capital given on Tuesday, September 29. TH Capital maintained it with “Buy” rating and $11 target in Tuesday, September 29 report. The rating was maintained by TH Capital with “Buy” on Wednesday, November 11. The company was maintained on Wednesday, November 11 by Roth Capital. The stock of Zosano Pharma Corporation (NASDAQ:ZSAN) earned “Neutral” rating by Ladenburg Thalmann on Thursday, August 11.

More recent Zosano Pharma Corporation (NASDAQ:ZSAN) news were published by: Seekingalpha.com which released: “Zosano Pharma’s (ZSAN) CEO John Walker on Q1 2018 Results – Earnings Call Transcript” on May 16, 2018. Also Globenewswire.com published the news titled: “Zosano Appoints Steven A. Elms to Board of Directors” on May 22, 2018. Globenewswire.com‘s news article titled: “Market Trends Toward New Normal in ANSYS, Pearson, Qualys, HB Fuller, Cabot Microelectronics, and Zosano …” with publication date: May 31, 2018 was also an interesting one.

The stock increased 0.98% or $0.25 during the last trading session, reaching $25.85. About 1,906 shares traded. Malvern Bancorp, Inc. (MLVF) has risen 14.32% since June 13, 2017 and is uptrending. It has outperformed by 1.75% the S&P500.

Seidman Lawrence B holds 9.01% of its portfolio in Malvern Bancorp, Inc. for 454,761 shares. Clover Partners L.P. owns 172,215 shares or 4.99% of their US portfolio. Moreover, Fj Capital Management Llc has 1.83% invested in the company for 653,100 shares. The Virginia-based Ejf Capital Llc has invested 1.34% in the stock. Banc Funds Co Llc, a Illinois-based fund reported 542,894 shares.

Malvern Bancorp, Inc. operates as the holding firm for Malvern Federal Savings Bank that provides various banking services and products to consumer and business clients in Pennsylvania. The company has market cap of $166.75 million. The firm offers checking accounts, retirement accounts, money market accounts, time and savings accounts, interest and non-interest bearing accounts, NOW accounts, and CDARS/ICS reciprocal deposits; and debit and credit card, wire transfer, automated teller, Internet banking, ACH origination, safe deposit box, telephone banking, and mobile banking services. It has a 31.95 P/E ratio. It also provides residential mortgage loans, such as one class and one-to four-family first lien residential mortgage loans; residential and commercial construction loans, and land loans; commercial loans, including commercial real estate loans, multi-family real estate loans, industrial loans, and commercial business loans; and consumer loans, such as home equity lines of credit, second mortgage loans, and unsecured consumer lines of credit.

Malvern Bancorp, Inc. (NASDAQ:MLVF) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts